FDA Warning: Serotonin Syndrome
In 2006, the FDA issued a warning against using triptan drugs and certain antidepressant medications at the same time. Combining a triptan with a selective serotonin reuptake inhibitor (SSRI) or selective serotonin norepinephrine reuptake inhibitor (SSRI) can result in serotonin syndrome. Serotonin syndrome is a potentially life-threatening condition caused by excess levels of the brain chemical serotonin.
...Today Eli Lilly and Co. announced the FDA approval of Cymbalta (duloxetine HCI) for the... Read more »
...U.S. Food and Drug Administration requesting that Cymbalta (duloxetine) be approved for the... Read more »
If Cymbalta (duloxetine) sounds familiar, it may be because it recently received FDA approval for... Read more »
...seen the television commercials or magazine ads for Cymbalta, and you might be wondering what... Read more »
...serotonin-norepinephrine reuptake inhibitor (SNRI) that works by helping to restore the balance... Read more »
LOS ANGELES (Ivanhoe Broadcast News) -- About 17 million Americans suffer depression, which is the fourth-leading cause of disability in this... Read summary »
(Ivanhoe Newswire) -- Previous research has linked red wine to protection from heart disease and certain types of cancer, and a new study details how... Read summary »
(Ivanhoe Newswire) New research sheds light on how a cholesterol drug works in the body. The study is significant because the drug ezetimibe (Zetia)... Read summary »
(Ivanhoe Newswire) -- A diagnosis of cancer doesn't necessarily mean an end to an older patient's career. A new study from Pennsylvania State... Read summary »
(Ivanhoe Newswire) -- Ginkgo biloba has long been used as a natural brain booster. Now, researchers say it may also protect against brain damage... Read summary »